— Know what they know.
Not Investment Advice
Also trades as: 600196.SS (SHH) · $vol 96M · 2196.HK (HKSE) · $vol 9M

SFOSF OTC

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
1W: +11.4% 1M: +11.4% 3M: +21.3% YTD: -11.9% 1Y: -30.0% 3Y: +10.9% 5Y: -51.0%
$2.45
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 72 · $6.5B mcap · 941M float · 0.0000% daily turnover · Short 57% of daily vol

📊 Key Metrics

TTM
$62B
Revenue
+53.9% YoY
$5B
Net Income
+76.0% YoY
$670M
Free Cash Flow
+52.8% YoY
49.5%
Gross Margin
6.2%
Op. Margin
8.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE10.7%
ROA4.2%
ROIC6.3%

Valuation

P/E18.8
P/B1.3
EV/EBITDA0.0

Leverage

Debt/Equity0.81
Current Ratio0.90
Interest Cov.2.8x

Quality Scores

Piotroski F7/9
Altman Z—
Beneish M-1.86

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms